APLLTD - Technical Analysis with Chart Patterns & Indicators
Back to ListTechnical Rating: 2.8
| Stock Code | APLLTD | Market Cap | 13,273 Cr. | Current Price | 676 ₹ | High / Low | 1,108 ₹ |
| Stock P/E | 26.2 | Book Value | 267 ₹ | Dividend Yield | 1.63 % | ROCE | 11.3 % |
| ROE | 9.68 % | Face Value | 2.00 ₹ | DMA 50 | 758 ₹ | DMA 200 | 860 ₹ |
| Chg in FII Hold | 0.19 % | Chg in DII Hold | -0.13 % | PAT Qtr | 149 Cr. | PAT Prev Qtr | 179 Cr. |
| RSI | 25.7 | MACD | -26.7 | Volume | 50,753 | Avg Vol 1Wk | 43,586 |
| Low price | 665 ₹ | High price | 1,108 ₹ | PEG Ratio | -7.92 | Debt to equity | 0.27 |
| 52w Index | 2.41 % | Qtr Profit Var | 74.0 % | EPS | 24.0 ₹ | Industry PE | 27.6 |
📊 Chart & Trend: Current price (676 ₹) is trading well below both 50 DMA (758 ₹) and 200 DMA (860 ₹), reflecting a strong bearish undertone. Support lies near 665 ₹, resistance at 758–860 ₹.
📉 Momentum Indicators: RSI at 25.7 indicates oversold conditions. MACD at -26.7 confirms bearish momentum. Bollinger Bands show price hugging the lower band, signaling weakness but potential for a short-term rebound.
📈 Volume Trends: Current volume (50,753) is slightly above the 1-week average (43,586), showing modest participation but not strong conviction.
🎯 Entry Zone: 665–680 ₹ (near support, oversold RSI may trigger bounce).
🎯 Exit Zone: 750–770 ₹ (near 50 DMA resistance; profit booking advisable).
🔎 Trend Status: The stock is trending downward with oversold signals. Short-term rebound possible, but long-term weakness persists below moving averages.
Positive
- Dividend yield at 1.63% adds income appeal.
- EPS at 24.0 ₹ provides a steady earnings base.
- FII holding increased (+0.19%), showing marginal foreign investor interest.
Limitation
- Low ROCE (11.3%) and ROE (9.68%) highlight weak capital efficiency.
- PEG ratio (-7.92) indicates poor growth valuation metrics.
- Stock trading well below 200 DMA reflects long-term weakness.
Company Negative News
- Quarterly PAT declined (149 Cr vs 179 Cr), showing earnings pressure.
- DII holding decreased (-0.13%), reflecting reduced domestic institutional confidence.
Company Positive News
- Quarterly profit variance (74.0%) highlights operational volatility but potential upside in select quarters.
- Near debt-free status (Debt-to-equity 0.27) supports financial stability.
Industry
- Industry PE at 27.6 suggests moderate sector valuation.
- Pharmaceutical sector benefits from healthcare demand and regulatory support, though competition remains high.
Conclusion
⚖️ APLLTD is trending downward, trading below key moving averages with oversold RSI. Entry near 665–680 ₹ offers tactical opportunity for short-term rebound toward 750–770 ₹. Fundamentals show dividend support and stable EPS, but weak efficiency metrics and declining PAT limit upside. Best suited for cautious swing trades with strict stop-loss near 665 ₹.
Would you like me to build a pharma sector basket overlay with peer benchmarking, so you can evaluate whether APLLTD’s weak technicals are offset by stronger setups in competitors like AJANTPHARM or AKUMS?